Viewing nowSimcol Tablet (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 200308855 · Notified 2003.01.14 · Insurance code 657801200
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
This medicine helps reduce the risk of cardiovascular disease. It can lower the risk of death from coronary heart disease, non-fatal myocardial infarction, and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke. It also reduces the associated risks related to coronary and non-coronary vascular interventions. For patients with hyperlipidemia, it is used to lower total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels, while increasing HDL cholesterol levels. In pediatric patients aged 10 to 17 years with specific criteria of heterozygous familial hypercholesterolemia, it helps effectively manage cholesterol levels in conjunction with diet. This drug is used to reduce the risk of cardiovascular disease and improve blood lipid levels.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate based on the initial LDL cholesterol level before starting treatment, the treatment target, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have been taking 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not feasible. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when administered alone or in combination with bile acid sequestrants. When this medicine is administered concomitantly with fibrates (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor closely.
Pediatric patients 10 ~ 17 years of age with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose as appropriate for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or longer between dose adjustments.
This medication can cause muscle problems; therefore, if symptoms such as muscle pain or weakness occur, you must inform your doctor immediately. Extra caution is needed, especially when taking high doses, as the risk of myopathy is increased. Women who are pregnant, breastfeeding, allergic to this drug, or have liver disease should not take this medication. Additionally, if taken with certain other drugs, the risk of myopathy may increase, so be sure to consult your doctor or pharmacist if you are taking any other medications. Patients with poor liver function or those who consume large amounts of alcohol should have their liver health checked regularly while taking this drug. Patients with impaired kidney function, hypothyroidism, muscle disorders, or a history of muscle problems should also take caution while using this drug. Elderly individuals and women have a higher risk of developing myopathy and should be used even more cautiously. As this drug is metabolized in the liver, its administration may need to be adjusted or discontinued if liver function tests are abnormal. Women who are pregnant or may become pregnant must use contraception, and if pregnancy is confirmed, the medication should be stopped immediately. It is recommended that women who are breastfeeding discontinue nursing while taking this drug. If unexplained muscle pain, tenderness, or weakness persists while taking this drug, you should consult a healthcare professional immediately. This drug has many drug interactions, so when receiving a new prescription or taking new medications, be sure to inform your healthcare provider that you are taking this drug. In case of overdose, seek medical attention immediately. Lastly, this medication should be stored out of the reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to air and moisture and must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the effectiveness and safety of the medication for a longer duration.
Yellow-brown oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.